Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.64%
|
$0
$0.46 P/Share
|
|
Jul 22
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.65%
|
$165,000
$55.23 P/Share
|
|
Jul 16
2024
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,480
-1.11%
|
$191,400
$55.16 P/Share
|
|
Jul 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-0.77%
|
$3,360,000
$56.57 P/Share
|
|
Jul 15
2024
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,520
-1.69%
|
$908,600
$55.09 P/Share
|
|
Jul 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.37%
|
$270,000
$54.02 P/Share
|
|
Jul 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.64%
|
$0
$0.46 P/Share
|
|
Jul 01
2024
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-0.13%
|
$103,150
$50.19 P/Share
|
|
Jul 01
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
20,000
-2.42%
|
$1,000,000
$50.15 P/Share
|
|
Jul 01
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,067
-0.29%
|
$103,350
$50.19 P/Share
|
|
Jul 01
2024
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,222
-0.23%
|
$211,100
$50.19 P/Share
|
|
Jul 01
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.64%
|
$150,000
$50.08 P/Share
|
|
Jul 01
2024
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,120
-0.16%
|
$106,000
$50.19 P/Share
|
|
Jun 21
2024
|
Rebecca Chambers Director |
SELL
Open market or private sale
|
Direct |
260
-2.61%
|
$11,700
$45.99 P/Share
|
|
Jun 17
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-1.17%
|
$1,760,000
$44.59 P/Share
|
|
Jun 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,000
-1.35%
|
$235,000
$47.6 P/Share
|
|
Jun 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.61%
|
$0
$0.46 P/Share
|
|
May 28
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-6.48%
|
$3,000,000
$50.13 P/Share
|
|
May 28
2024
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
3,000
-0.64%
|
$150,000
$50.0 P/Share
|
|
May 20
2024
|
Rebecca Chambers Director |
SELL
Open market or private sale
|
Direct |
964
-8.84%
|
$43,380
$45.39 P/Share
|
|
May 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-2.09%
|
$1,840,000
$46.75 P/Share
|
|
May 13
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-1.08%
|
$270,000
$45.59 P/Share
|
|
May 13
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+3.1%
|
$0
$0.46 P/Share
|
|
May 01
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
38,549
-1.28%
|
$1,619,058
$42.76 P/Share
|
|
Apr 24
2024
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+15.54%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+25.35%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Donald B Milder Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+1.57%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+0.76%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+9.7%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+27.01%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+0.41%
|
$173,292
$42.41 P/Share
|
|
Apr 24
2024
|
Rebecca Chambers Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,126
+27.44%
|
$173,292
$42.41 P/Share
|
|
Apr 16
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
1,451
-0.14%
|
$58,040
$40.0 P/Share
|
|
Apr 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-3.2%
|
$240,000
$40.96 P/Share
|
|
Apr 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+3.1%
|
$0
$0.46 P/Share
|
|
Apr 01
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,067
-0.28%
|
-
|
|
Apr 01
2024
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,222
-0.22%
|
-
|
|
Apr 01
2024
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,063
-0.1%
|
-
|
|
Apr 01
2024
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,119
-0.16%
|
-
|
|
Mar 18
2024
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
40,000
-1.93%
|
$1,640,000
$41.22 P/Share
|
|
Mar 12
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,000
-1.58%
|
$252,000
$42.25 P/Share
|
|
Mar 12
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+3.07%
|
$0
$0.46 P/Share
|
|
Feb 16
2024
|
Hill, Mitch C. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,812
+7.47%
|
-
|
|
Feb 16
2024
|
Thomas Tu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,812
+4.25%
|
-
|
|
Feb 16
2024
|
Andrew Hykes President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,786
+7.94%
|
-
|
|
Jan 01
2024
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,063
-0.24%
|
$196,032
$64.92 P/Share
|
|
Jan 01
2024
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
2,197
-0.11%
|
$140,608
$64.92 P/Share
|
|
Jan 01
2024
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,783
-0.19%
|
$114,112
$64.92 P/Share
|
|
Jan 01
2024
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,742
-0.34%
|
$111,488
$64.92 P/Share
|
|
Dec 15
2023
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
25,000
-0.59%
|
$1,625,000
$65.2 P/Share
|